{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#34 - Cary Claiborne, CEO of Adial Pharmaceuticals","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/8253ad15\"></iframe>","width":"100%","height":180,"duration":884,"description":"Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.What you'll get out of this episode:Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.To learn more about our guests and their companies:LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/Company LinkedIn: https://www.linkedin.com/company/adialpharma/Website: https://www.adial.com/Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}